This is a citizen science site -- you can contribute by investing and sharing your time.
Common knowledge amoung some professionals (MD and ND):
Vitamin D: Individuals with CKD may have reduced kidney function, which can affect the activation of vitamin D. Vitamin D supplements might be prescribed by healthcare professionals to help manage low vitamin D levels often seen in CKD. However, the dosage and type of vitamin D supplementation should be determined by healthcare providers.
Omega-3 Fatty Acids: Omega-3 supplements containing EPA and DHA have anti-inflammatory properties and may have potential benefits in supporting cardiovascular health in individuals with CKD. They might help reduce inflammation and decrease the risk of cardiovascular complications associated with CKD. However, their specific role in CKD management requires further research.
Probiotics: The use of probiotics in CKD is an area of ongoing research. Some studies suggest that probiotics might have potential benefits in managing complications related to CKD, such as reducing uremic toxins or improving gut health. However, more research is needed to establish their efficacy and safety in individuals with CKD.
Phosphate Binders and Vitamin B Complex: In later stages of CKD, phosphate binders might be prescribed to control phosphate levels in the blood. Additionally, vitamin B complex supplements might be recommended to address deficiencies associated with CKD.
The Studies below identify bacteria. Check if it has already been reviewed.
| 1 | 📚 |
Altered gut microbiota and microbial biomarkers associated with chronic kidney disease.
MicrobiologyOpen (Microbiologyopen ) Vol: Issue: Pages: e00678 Pub: 2018 Aug 7 ePub: 2018 Aug 7 Authors Lun H,Yang W,Zhao S,Jiang M,Xu M,Liu F,Wang Y |
| 2 | 📚 |
Association of subjective global assessment of nutritional status with gut microbiota in hemodialysis patients: a case-control study.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association (Nephrol Dial Transplant ) Vol: 36 Issue: 6 Pages: 1104-1111 Pub: 2021 May 27 ePub: Authors Lin TY,Hung SC |
| 3 | 📚 |
Chronic kidney disease alters intestinal microbial flora.
Kidney international (Kidney Int ) Vol: 83 Issue: 2 Pages: 308-15 Pub: 2013 Feb ePub: 2012 Sep 19 Authors Vaziri ND,Wong J,Pahl M,Piceno YM,Yuan J,DeSantis TZ,Ni Z,Nguyen TH,Andersen GL |
| 4 | 📚 |
Exploring the potential link between gut microbiota and chronic kidney disease in causality: A 2-sample Mendelian randomization study.
Medicine (Medicine (Baltimore) ) Vol: 103 Issue: 43 Pages: e40236 Pub: 2024 Oct 25 ePub: Authors Zhang WW,Huo JL,Xiao MD,Xu YJ,Zhou J |
| 5 | 📚 |
Genetic Evidence for the Causal Relationship Between Gut Microbiota and Diabetic Kidney Disease: A Bidirectional, Two-Sample Mendelian Randomisation Study.
Journal of diabetes research (J Diabetes Res ) Vol: 2024 Issue: Pages: 4545595 Pub: 2024 ePub: 2024 Oct 23 Authors Zhang Y,Zhao L,Jia Y,Zhang X,Han Y,Lu P,Yuan H |
| 6 | 📚 |
High Mortality Risk in Chronic Kidney Disease and End Stage Kidney Disease Patients with Clostridium Difficile Infection: A Systematic Review and Meta-analysis.
Journal of nature and science (J Nat Sci ) Vol: 1 Issue: 4 Pages: Pub: 2015 Apr ePub: Authors Thongprayoon C,Cheungpasitporn W,Phatharacharukul P,Mahaparn P,Bruminhent J |
| 7 | 📚 |
Integrative metagenomic and metabolomic analyses reveal severity-specific signatures of gut microbiota in chronic kidney disease.
Theranostics (Theranostics ) Vol: 10 Issue: 12 Pages: 5398-5411 Pub: 2020 ePub: 2020 Apr 6 Authors Wu IW,Gao SS,Chou HC,Yang HY,Chang LC,Kuo YL,Dinh MCV,Chung WH,Yang CW,Lai HC,Hsieh WP,Su SC |
| 8 | 📚 |
Is there interaction between gut microbial profile and cardiovascular risk in chronic kidney disease patients?
Future microbiology (Future Microbiol ) Vol: 10 Issue: 4 Pages: 517-26 Pub: 2015 ePub: Authors Barros AF,Borges NA,Ferreira DC,Carmo FL,Rosado AS,Fouque D,Mafra D |
| 9 | 📚 |
Longitudinal Pilot Evaluation of the Gut Microbiota Comparing Patients With and Without Chronic Kidney Disease.
Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation (J Ren Nutr ) Vol: 34 Issue: 4 Pages: 302-312 Pub: 2024 Jul ePub: 2024 Jan 28 Authors Pourafshar S,Sharma B,Allen J,Hoang M,Lee H,Dressman H,Tyson CC,Mallawaarachchi I,Kumar P,Ma JZ,Lin PH,Scialla JJ |
| 10 | 📚 |
Metagenomic profiling of gut microbiome in early chronic kidney disease.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association (Nephrol Dial Transplant ) Vol: 36 Issue: 9 Pages: 1675-1684 Pub: 2021 Aug 27 ePub: Authors Sato N,Kakuta M,Hasegawa T,Yamaguchi R,Uchino E,Murashita K,Nakaji S,Imoto S,Yanagita M,Okuno Y |
| 11 | 📚 |
Slight Changes in the Gut Microbiome in Early-stage Chronic Kidney Disease of Unknown Etiology.
Microbes and environments (Microbes Environ ) Vol: 38 Issue: 3 Pages: Pub: 2023 ePub: Authors Banjong D,Pongking T,Tran NTD,Pinlaor S,Dangtakot R,Intuyod K,Anutrakulchai S,Cha'on U,Pinlaor P |
| 12 | 📚 |
The Association between Gut Microbiota and Uremia of Chronic Kidney Disease.
Microorganisms (Microorganisms ) Vol: 8 Issue: 6 Pages: Pub: 2020 Jun 16 ePub: 2020 Jun 16 Authors Kim JE,Kim HE,Park JI,Cho H,Kwak MJ,Kim BY,Yang SH,Lee JP,Kim DK,Joo KW,Kim YS,Kim BS,Lee H |
| 13 | 📚 |
The compositional and functional imbalance of the gut microbiota in CKD linked to disease patterns.
Journal of translational medicine (J Transl Med ) Vol: 22 Issue: 1 Pages: 773 Pub: 2024 Aug 16 ePub: 2024 Aug 16 Authors Li J,Shen Y,Yan K,Wang S,Jiao J,Chi H,Zhong JC,Dong Y,Wang P |
| 14 | 📚 |
The Phosphate Binder Ferric Citrate Alters the Gut Microbiome in Rats with Chronic Kidney Disease.
The Journal of pharmacology and experimental therapeutics (J Pharmacol Exp Ther ) Vol: 367 Issue: 3 Pages: 452-460 Pub: 2018 Dec ePub: 2018 Oct 4 Authors Lau WL,Vaziri ND,Nunes ACF,Comeau AM,Langille MGI,England W,Khazaeli M,Suematsu Y,Phan J,Whiteson K |
| 15 | 📚 |
The relationship between colonization of Oxalobacter formigenes serum oxalic acid and endothelial dysfunction in hemodialysis patients: from impaired colon to impaired endothelium.
Medical hypotheses (Med Hypotheses ) Vol: 84 Issue: 3 Pages: 273-5 Pub: 2015 Mar ePub: 2015 Jan 19 Authors Turkmen K,Erdur FM |
The Studies below identify substances that has been tried with positive changes (for at least some symptoms in the study). Check if it has already been reviewed.
| 16 | 📚 |
Akkermansia muciniphila ameliorates chronic kidney disease interstitial fibrosis via the gut-renal axis.
Microbial pathogenesis (Microb Pathog ) Vol: 174 Issue: Pages: 105891 Pub: 2023 Jan ePub: 2022 Nov 23 Authors Pei T,Hu R,Wang F,Yang S,Feng H,Li Q,Zhang J,Yan S,Ju L,He Z,Han Z,Yang A,Xiao W,Ma Y,Wang M |
| 17 | 📚 |
Ameliorating effect of probiotics in a rat model of chronic kidney disease.
PloS one (PLoS One ) Vol: 18 Issue: 3 Pages: e0281745 Pub: 2023 ePub: 2023 Mar 30 Authors Inatomi T,Honma M |
| 18 | 📚 |
Anthraquinone-containing compound in rhubarb prevents indole production via functional changes in gut microbiota.
Journal of natural medicines (J Nat Med ) Vol: 75 Issue: 1 Pages: 116-128 Pub: 2021 Jan ePub: 2020 Oct 19 Authors Takayama K,Maehara S,Tabuchi N,Okamura N |
| 19 | 📚 |
Chronic kidney disease and gut microbiota.
Heliyon (Heliyon ) Vol: 9 Issue: 8 Pages: e18991 Pub: 2023 Aug ePub: 2023 Aug 7 Authors Amini Khiabani S,Asgharzadeh M,Samadi Kafil H |
| 20 | 📚 |
Effects of Bifidobacterium bifidum tetragonum tablets and Jin Gui Ren Qi Pill on intestinal flora and metabolism in patients with diabetic kidney disease.
Frontiers in pharmacology (Front Pharmacol ) Vol: 15 Issue: Pages: 1346168 Pub: 2024 ePub: 2024 Jul 29 Authors Zhang CY,Yue DJ,Wang D,Wu FF |
| 21 | 📚 |
Gut Microbiota-Targeted Interventions in the Management of Chronic Kidney Disease.
Seminars in nephrology (Semin Nephrol ) Vol: 43 Issue: 2 Pages: 151408 Pub: 2023 Aug 22 ePub: 2023 Aug 22 Authors Sumida K,Pierre JF,Yuzefpolskaya M,Colombo PC,Demmer RT,Kovesdy CP |
| 22 | 📚 |
Lactobacillus rhamnosus GG aggravates vascular calcification in chronic kidney disease: A potential role for extracellular vesicles.
Life sciences (Life Sci ) Vol: Issue: Pages: 122001 Pub: 2023 Aug 23 ePub: 2023 Aug 23 Authors Wei J,Li Z,Fan Y,Feng L,Zhong X,Li W,Guo T,Ning X,Li Z,Ou C |
| 23 | 📚 |
The Dietary Fermentable Fiber Inulin Alters the Intestinal Microbiome and Improves Chronic Kidney Disease Mineral-Bone Disorder in a Rat Model of CKD.
bioRxiv : the preprint server for biology (bioRxiv ) Vol: Issue: Pages: Pub: 2023 Jan 31 ePub: 2023 Jan 31 Authors Biruete A,Chen NX,Metzger CE,Srinivasan S,Oâ Neill K,Fallen PB,Fonseca A,Wilson HE,de Loor H,Evenepoel P,Swanson KS,Allen MR,Moe SM |
| 24 | 📚 |
The effect of probiotics on serum levels of cytokine and endotoxin in peritoneal dialysis patients: a randomised, double-blind, placebo-controlled trial.
Beneficial microbes (Benef Microbes ) Vol: 6 Issue: 4 Pages: 423-30 Pub: 2015 ePub: 2015 Feb 12 Authors Wang IK,Wu YY,Yang YF,Ting IW,Lin CC,Yen TH,Chen JH,Wang CH,Huang CC,Lin HC |
| 25 | 📚 |
The Effects of Probiotic Lactobacillus rhamnosus GG on Fecal Flora and Serum Markers of Renal Injury in Mice with Chronic Kidney Disease.
Frontiers in bioscience (Landmark edition) (Front Biosci (Landmark Ed) ) Vol: 28 Issue: 9 Pages: 226 Pub: 2023 Sep 26 ePub: Authors Zhu L,Niu J,Tang XC,Shan LH,Xiao L,Wang YQ,Yin LY,Yu YY,Li XR,Zhou P |
The following items have been cited in the above studies
| ID | Studies | Name | AKA |
|---|---|---|---|
| 206 | 1 | (2->1)-beta-D-fructofuranan {Inulin} | Fructan, Polyfructose, Alpha-D-glucopyranosyl-beta-D-fructofuranosyl-D-fructofuranoside, usually from Chicory root, Jerusalem artichoke |
| 1933 | 1 | Akkermansia muciniphila {Pendulum Probiotic} | |
| 32 | 1 | bacillus subtilis {B.Subtilis } | Hay bacillus, grass bacillus,Vibrio subtilis |
| 1737 | 1 | bifidobacterium bifidum {B. bifidum} | |
| 48 | 1 | Bifidobacterium catenulatum subsp. catenulatum {Bifidobacterium catenulatum} | B. catenulatum, includes Bifidobacterium kashiwanohense: |
| 50 | 1 | bifidobacterium longum {B.Longum } | May include Bifidobacterium longum subsp. infantis and Bifidobacterium longum subsp. longum |
| 120 | 1 | dietary fiber | |
| 297 | 2 | Escherichia coli Nissle 1917 {Mutaflor} | In use since 1917 |
| 241 | 2 | Lacticaseibacillus paracasei {L.paracasei} | Was also known as Lactobacillus casei subsp. pseudoplantarum |
| 246 | 2 | Lacticaseibacillus rhamnosus {l. rhamnosus} | lactobacillus rhamnosus, Lactobacillus casei subsp. rhamnosus |
| 243 | 1 | Lactobacillus plantarum {L. plantarum} | lactobacillus plantarum, Lactobacillus arabinosus |
| 361 | 1 | Rheum × hybridum {Rhubarb} | Rhei or Dahuang |
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]
